Analysis of genes involved in 6-deoxyhexose biosynthesis and transfer in Saccharopolyspora erythraea.
Glycosylation represents an attractive target for protein engineering of novel antibiotics, because specific attachment of one or more deoxysugars is required for the bioactivity of many antibiotic and antitumour polyketides. However, proper assessment of the potential of these enzymes for such combinatorial biosynthesis requires both more precise information on the enzymology of the pathways and also improved Escherichia coli-actinomycete shuttle vectors. New replicative vectors have been constructed and used to express independently the dnmU gene of Streptomyces peucetius and the eryBVII gene of Saccharopolyspora erythraea in an eryBVII deletion mutant of Sac. erythraea. Production of erythromycin A was obtained in both cases, showing that both proteins serve analogous functions in the biosynthetic pathways to dTDP-L-daunosamine and dTDP-L-mycarose, respectively. Over-expression of both proteins was also obtained in S. lividans, paving the way for protein purification and in vitro monitoring of enzyme activity. In a further set of experiments, the putative desosaminyltransferase of Sac. erythraea, EryCIII, was expressed in the picromycin producer Streptomyces sp. 20032, which also synthesises dTDP-D-desosamine. The substrate 3-alpha-mycarosylerythronolide B used for hybrid biosynthesis was found to be glycosylated to produce erythromycin D only when recombinant EryCIII was present, directly confirming the enzymatic role of EryCIII. This convenient plasmid expression system can be readily adapted to study the directed evolution of recombinant glycosyltransferases.
Doumith
M
M
Infectious Disease Group, Aventis Pharma, Hoechst Marion Roussel, Romainville, France. marie-cecile.raynal@aventis.com
Weingarten
P
P
Wehmeier
U F
UF
Salah-Bey
K
K
Benhamou
B
B
Capdevila
C
C
Michel
J M
JM
Piepersberg
W
W
Raynal
M C
MC
D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000378:metabolism; D001426:Bacterial Proteins; D001483:Base Sequence; D002237:Carbohydrate Dehydrogenases / Q000235:genetics; D017931:DNA Primers / Q000235:genetics; D004917:Erythromycin / Q000096:biosynthesis* / Q000737:chemistry / Q000378:metabolism; D004926:Escherichia coli / Q000235:genetics; D015870:Gene Expression; D005798:Genes, Bacterial; D005816:Genetic Complementation Test; D005822:Genetic Vectors; D006031:Glycosylation; D016695:Glycosyltransferases / Q000235:genetics; D010088:Oxidoreductases / Q000235:genetics; D010957:Plasmids / Q000235:genetics; D016930:Saccharopolyspora / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D017931:DNA Primers; D004917:Erythromycin; D010088:Oxidoreductases; D002237:Carbohydrate Dehydrogenases; C107149:dnmV protein, Streptomyces peucetius; C111820:eryBII protein, Saccharopolyspora erythraea; D016695:Glycosyltransferases; C111822:EryBV protein, Saccharopolyspora erythraea; C111821:EryCIII protein, Saccharopolyspora erythraea